A detailed history of Heritage Family Offices, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Heritage Family Offices, LLP holds 6,781 shares of NVO stock, worth $726,923. This represents 0.42% of its overall portfolio holdings.

Number of Shares
6,781
Previous 6,742 0.58%
Holding current value
$726,923
Previous $962 Million 16.1%
% of portfolio
0.42%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$119.07 - $145.42 $4,643 - $5,671
39 Added 0.58%
6,781 $807 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $827,310 - $990,467
6,742 New
6,742 $962 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Heritage Family Offices, LLP Portfolio

Follow Heritage Family Offices, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Family Offices, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Family Offices, LLP with notifications on news.